Hospitalized girls prompt Gardasil recall

A bolt out of the blue hit Merck's Gardasil, with two 14-year-old girls in Spain hospitalized after receiving the human papillomavirus vaccine. Health authorities in Spain have now withdrawn an entire batch--nearly 76,000 doses--of the shot. Report

Suggested Articles

Pfizer has new data to boast about on its Prevnar 13 follow-up, but rival Merck already has a lead in the same group of patients.

Sanofi lost an appeal challenging the ban on its dengue vaccine Dengvaxia in the Philippines, despite an ongoing outbreak there.

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.